相关实验视频

Updated: Jun 23, 2025

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes

Published on: May 5, 2020

在人类iPSC基础的心肌病模型中,对缺陷的早期内基因组分布进行3D计算建模

Hafiza Nosheen Saleem^1,2, Nadezda Ignatyeva^1,2, Christiaan Stuut^3,4

¹Heart Research Center Goettingen, Department of Cardiology and Pneumology, University Medical Center Goettingen, Georg-August University of Goettingen, 37077 Goettingen, Germany.

|June 19, 2024

概括

一个新的计算模型量化了细胞中早期的内分体分布. 这种方法在扩张性心肌病模型中揭示了异常的囊泡集群,通过RhoA II治疗进行了纠正,改善了货物运输.

科学领域:

细胞生物学细胞生物学
生物物理学的生物物理.
计算生物学计算生物学

背景情况:

细胞内载荷的传递依赖于囊泡的运输,克拉介导内细胞分裂 (CME) 是通过早期内体细胞的关键途径.
内分体的动态性质挑战了定量分析,需要先进的建模方法.
扩展性心肌病 (DCM) 模型由于CME信号受损而表现出缺陷的囊泡分布.

研究的目的:

引入一种新的计算建模方法来评估内体分布.
分析带有DCM相关突变的诱导多能干细胞衍生心肌细胞 (iPSC-CMs) 的早期内基因组分布.
调查RhoA II治疗对拯救内分体分布缺陷的影响.

主要方法:

开发了一个3D球形计算模型用于内体分布分析.
使用了具有TPM1-L185F和TNT-R141W突变 (MUT) 和野生类型 (WT) 控制的iPSC-CM.
使用3D共聚焦和超分辨率STED显微镜对EEA1-阳性囊泡进行成像.

主要成果:

与WT对照组相比,在MUT iPSC-CM中发现了早期内分体群的双模分离.
在MUT iPSC-CM中观察到血局部化的早期内,表明CME受损.
在接受RhoAII治疗的MUT iPSC-CM中,证明了双模式囊泡局部化的逆转,表明恢复了均分布.

结论:

开发的3D球形建模方法有效地评估了基于细胞的疾病模型中的早期内分体分布.
在DCM iPSC-CM中异常的早期内分体分布可以通过RhoA II治疗来挽救,恢复CME依赖的信号.
这种方法在各种生理和病理条件下提供了对内体网络动态的新见解.

关键词:

子一个子计算建模计算建模扩张性心肌病症扩张性心肌病症内分泌体内分泌体内分泌体内分泌体心脏衰竭是因为心脏衰竭.人类的iPSCs.信号处理信号处理信号处理信号传导的信号传导.

更多相关视频

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.

Published on: March 3, 2021

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Published on: March 14, 2021

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...